Current and historical daily PE Ratio for Biomark Diagnostics Inc (
XCNQ:BUX
) from 2014 to Sep 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biomark Diagnostics stock (XCNQ:BUX) PE ratio as of Sep 21 2024 is 0.
More Details
Biomark Diagnostics Inc (XCNQ:BUX) PE Ratio (TTM) Chart
Biomark Diagnostics Inc (XCNQ:BUX) PE Ratio (TTM) Historical Data
View and export this data going back to 2014. Start your Free Trial
Total 1286
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Biomark Diagnostics PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-09-22 | At Loss | 2024-07-18 | At Loss |
| 2024-09-20 | At Loss | 2024-07-17 | At Loss |
| 2024-09-19 | At Loss | 2024-07-16 | At Loss |
| 2024-09-18 | At Loss | 2024-07-15 | At Loss |
| 2024-09-17 | At Loss | 2024-07-12 | At Loss |
| 2024-09-16 | At Loss | 2024-07-11 | At Loss |
| 2024-09-13 | At Loss | 2024-07-10 | At Loss |
| 2024-09-12 | At Loss | 2024-07-09 | At Loss |
| 2024-09-11 | At Loss | 2024-07-08 | At Loss |
| 2024-09-10 | At Loss | 2024-07-05 | At Loss |
| 2024-09-09 | At Loss | 2024-07-04 | At Loss |
| 2024-09-06 | At Loss | 2024-07-03 | At Loss |
| 2024-09-05 | At Loss | 2024-07-02 | At Loss |
| 2024-09-04 | At Loss | 2024-07-01 | At Loss |
| 2024-09-03 | At Loss | 2024-06-28 | At Loss |
| 2024-08-30 | At Loss | 2024-06-27 | At Loss |
| 2024-08-29 | At Loss | 2024-06-26 | At Loss |
| 2024-08-28 | At Loss | 2024-06-25 | At Loss |
| 2024-08-27 | At Loss | 2024-06-24 | At Loss |
| 2024-08-26 | At Loss | 2024-06-21 | At Loss |
| 2024-08-23 | At Loss | 2024-06-20 | At Loss |
| 2024-08-22 | At Loss | 2024-06-19 | At Loss |
| 2024-08-21 | At Loss | 2024-06-18 | At Loss |
| 2024-08-20 | At Loss | 2024-06-17 | At Loss |
| 2024-08-19 | At Loss | 2024-06-14 | At Loss |
| 2024-08-16 | At Loss | 2024-06-13 | At Loss |
| 2024-08-15 | At Loss | 2024-06-12 | At Loss |
| 2024-08-14 | At Loss | 2024-06-11 | At Loss |
| 2024-08-13 | At Loss | 2024-06-10 | At Loss |
| 2024-08-12 | At Loss | 2024-06-07 | At Loss |
| 2024-08-09 | At Loss | 2024-06-06 | At Loss |
| 2024-08-08 | At Loss | 2024-06-05 | At Loss |
| 2024-08-07 | At Loss | 2024-06-04 | At Loss |
| 2024-08-06 | At Loss | 2024-06-03 | At Loss |
| 2024-08-02 | At Loss | 2024-05-31 | At Loss |
| 2024-08-01 | At Loss | 2024-05-30 | At Loss |
| 2024-07-31 | At Loss | 2024-05-29 | At Loss |
| 2024-07-30 | At Loss | 2024-05-28 | At Loss |
| 2024-07-29 | At Loss | 2024-05-27 | At Loss |
| 2024-07-26 | At Loss | 2024-05-24 | At Loss |
| 2024-07-25 | At Loss | 2024-05-23 | At Loss |
| 2024-07-24 | At Loss | 2024-05-22 | At Loss |
| 2024-07-23 | At Loss | 2024-05-21 | At Loss |
| 2024-07-22 | At Loss | 2024-05-20 | At Loss |
| 2024-07-19 | At Loss | 2024-05-17 | At Loss |
Biomark Diagnostics Inc (XCNQ:BUX) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biomark Diagnostics Inc
NAICS : 541380
SIC : 8681
ISIN : CA09073K1084
Description
Biomark Diagnostics Inc is a Canada-based oncology-focused company. It is engaged in the development of the early-stage cancer diagnostic technology platform. The company develops non-invasive cancer diagnostic solutions which will help to detect, monitor, and assess early cancer treatment. Its research and development are focused on the role that metabolomics plays in early cancer detection. The company's objective is to commercialize its inventive technology. and strive to increase the predictive accuracy in early-stage cancer detection.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers